Browsing the "Sofinnova Ventures" Tag →

02 2014 December
By FinSMEs
0 Comments

Audentes Therapeutics Closes $42.5M Series B Financing

Audentes Therapeutics, Inc., a San Francisco, CA-based biotechnology company committed to the development and commercialization of gene therapy products for...

Read More →
01 2014 December
By FinSMEs
0 Comments

Ascendis Pharma Completes $60M Series D Financing

Ascendis Pharma A/S, a Hellerup, Denmark- Palo Alto, California- and Heidelberg, Germany-based biotechnology company, completed a $60m Series D financing....

Read More →
02 2014 October
By FinSMEs
0 Comments

Aclaris Therapeutics Closes $21M Series B Financing

Aclaris Therapeutics, Inc., a Malvern, Pennsylvania-based specialty pharmaceutical company, closed on a $21m Series B financing. Backers included existing investors...

Read More →
26 2014 August
By FinSMEs
0 Comments

Civitas Therapeutics Completes $55M Series C Financing

Civitas Therapeutics, Inc., a Chelsea MA-based biopharmaceutical company developing and commercializing therapeutics using its proprietary technology, completed a $55m Series...

Read More →
21 2014 August
By FinSMEs
0 Comments

Guavus Raises $20M in Funding

Guavus Inc., a San Mateo, CA-based provider of big data analytics solutions for operational intelligence, raised $20m in funding. Backers...

Read More →
23 2014 July
By FinSMEs
0 Comments

Sofinnova Ventures Closes Ninth Fund at $500M

Sofinnova Ventures, a Menlo Park based investment firm dedicated to life science, closed its ninth fund at $500m. Led by...

Read More →
27 2014 May
By FinSMEs
0 Comments

Spark Therapeutics Completes $72.8M Series B Financing

Spark Therapeutics, a Philadelphia, PA-based late-stage company developing gene-based medicines for a wide range of rare, debilitating diseases, completed a...

Read More →
19 2014 May
By FinSMEs
0 Comments

Coherus BioSciences Closes $55M Series C Financing

Coherus BioSciences, Inc., a San Francisco, CA-based biologics platform company focused on biosimilars, closed a $55m Series C financing. New...

Read More →
15 2014 May
By FinSMEs
0 Comments

Sorbent Therapeutics Closes $6.5M Tranche in $15M Series D Financing

Sorbent Therapeutics, Inc., a Sunnyvale, California-based biopharmaceutical company developing therapies for cardiovascular and renal diseases, closed a $6.5m tranche in...

Read More →
22 2014 April
By FinSMEs
0 Comments

Principia Biopharma Raises $50M in Series B Financing

Principia Biopharma Inc., a South San Francisco, CA-based biopharmaceutical company, raised $50m in Series B financing. The round was led...

Read More →
11 2014 April
By FinSMEs
0 Comments

NuCana Completes $57M Series B Financing

NuCana, an Edinburgh, UK-based clinical stage biopharmaceutical company, completed a $57m Series B financing. The round was led by new...

Read More →
06 2014 March
By FinSMEs
0 Comments

ZS Pharma Completes $55M Series D Financing

ZS Pharma, a Coppell, TX-based specialty pharmaceutical company developing novel treatments for kidney, cardiovascular, and liver disorders, completed a $55m...

Read More →
11 2014 February
By FinSMEs
0 Comments

First Aid Shot Therapy Completes Series B Financing Round

First Aid Shot Therapy (F.A.S.T.), a Burlingame, California-based consumer healthcare company, completed its Series B financing round. The round –...

Read More →
08 2013 October
By FinSMEs
1 Comments

Versartis Completes $20M Series D Financing

Versartis, Inc., a Redwood City, CA-based biotechnology company developing novel therapeutics for patients with endocrine disorders, completed a $20m Series D financing....

Read More →